Nanosonics (ASX NAN) has a clear and reliable strategy for future development and a revolutionary monopolistic product (Trophon 2). The company also just achieved regulatory approvals in key markets and is selected by the guidelines in both Germany and France. The company also plans to rapidly expand into worldwide markets during FY19.
The company has developed a unique disinfection technology which is the first major innovation in High-Level Disinfection (HLD) for ultrasound probes. The products include Trophon machine, including Trophon EPR (first generation), Trophon2, consumables & accessories, and are sold in 3 different types of selling models.
The main product “Trophon” is an automated system that delivers HLD of ultrasound probes which is highly effective in killing bacteria, fungi, and viruses including the highly resistant HPV virus. North America is their most substantial market making up 89.62% of total revenue in FY18.
They also operate in some European and Asian countries, while still exploring chances to introduce their technology to other new countries. In addition, their successful business model, customer experience, product innovation, operational excellence, people engagement, and value creation, lay the foundation for success. Read more